Thousands of Chlorthalidone Blood Pressure Tablets Recalled Nationwide Over Testing Issue
Thousands of bottles of a commonly prescribed blood pressure medication are being recalled in the United States after the manufacturer reported that the tablets failed a quality test related to how they dissolve.
Inventia Healthcare Limited has initiated a nationwide recall involving 13,567 bottles of chlorthalidone tablets, 25 milligrams, with 100 tablets per bottle. The recall was initiated on September 3, 2026, and was classified by the U.S. Food and Drug Administration as a Class II recall on September 17.
The affected medication is a generic form of chlorthalidone, a diuretic commonly prescribed to help control high blood pressure and reduce excess fluid in the body.
Why the medication was recalled
According to the FDA enforcement information, the recall was triggered because the product failed dissolution specifications.
Dissolution testing is used to determine how a medication releases its active ingredient under laboratory conditions designed to simulate what happens after a tablet is taken. If a tablet does not dissolve as expected, the amount of medicine that becomes available for absorption can potentially be affected.
The available recall information does not indicate that every bottle of chlorthalidone is affected. The recall applies to specific product information and batches, so patients should check the details on their prescription packaging rather than assuming that all chlorthalidone products have been recalled.
The latest recall involves product manufactured by Inventia Healthcare Limited in India and distributed in the United States. The affected product is listed as chlorthalidone tablets, USP, 25 mg, in 100-count bottles.
The recall is currently listed as ongoing.
What is chlorthalidone used for?
Chlorthalidone belongs to a group of medicines known as diuretics, sometimes called water pills. According to MedlinePlus, it is used to treat high blood pressure and fluid retention.
The medication works partly by helping the kidneys remove excess salt and water from the body through urine. Reducing excess fluid can help lower blood pressure and may also help with swelling associated with certain medical conditions.
Chlorthalidone may be prescribed as part of a longer-term treatment plan for hypertension. Because high blood pressure often does not cause noticeable symptoms, patients may continue taking medication even when they feel well.
MedlinePlus advises patients to take chlorthalidone exactly as prescribed and not to stop taking it without first speaking with their doctor.
What does a Class II recall mean?
The FDA uses three main classifications for medical product recalls.
A Class I recall involves a situation in which use of or exposure to a product could cause serious adverse health consequences or death.
A Class II recall applies when use of or exposure to a product may cause temporary or medically reversible health consequences, or when the possibility of serious adverse health consequences is considered remote.
A Class III recall generally involves products that are not likely to cause an adverse health consequence but violate applicable regulations or standards.
The current chlorthalidone recall has been classified as Class II. That classification describes the FDA's assessment category for the recalled product and does not mean that every person who has taken the medication will experience a health problem.
What patients taking chlorthalidone should know
Patients who take chlorthalidone should check their prescription bottle or contact their pharmacy to determine whether their medication is part of the affected recall.
The most important information to compare can include the medication name, strength, bottle size, manufacturer, National Drug Code and lot or batch number.
Because the recall concerns a prescription blood pressure medication, patients should not make changes to their treatment independently.
The American Heart Association advises people with high blood pressure not to stop taking prescribed blood pressure medication without consulting a healthcare professional. It also recommends discussing concerns about medications with a doctor or pharmacist.
If a patient's bottle is confirmed to be part of the recall, a pharmacist or prescribing clinician can provide guidance about obtaining an alternative supply or determining the appropriate next step.
This is particularly important for people who rely on medication to keep their blood pressure under control.
Why dissolution testing matters
A tablet needs to release its active ingredient in a predictable way for the medicine to work as intended.
When a drug fails a dissolution specification, it does not automatically mean that the medicine is dangerous or that every tablet will fail in the same way. Rather, it indicates that the product did not meet the specified testing requirements.
Depending on the nature of the problem, inadequate dissolution can potentially affect how quickly or how much of the active ingredient becomes available for absorption.
For a medicine used to control blood pressure, inconsistent delivery of the active ingredient could be clinically important because maintaining stable treatment is an important part of hypertension management.
The specific recall notice does not provide additional details about the testing failure beyond the failed dissolution specification.
Checking your medication
Patients who are concerned about a possible recall can start by checking the label on their prescription bottle.
The product information should be compared with the details in the applicable FDA recall record. Patients can also contact the pharmacy that dispensed the medicine, particularly if the lot number or other identifying information is difficult to read.
Pharmacists can help determine whether a particular bottle is affected and can explain what alternatives may be available.
The American Heart Association also recommends monitoring blood pressure at home for people diagnosed with hypertension, while emphasizing that home monitoring does not replace medical care.
If a person experiences unusually high blood pressure or concerning symptoms, medical attention may be necessary. The American Heart Association states that a blood pressure reading above 180/120 mm Hg accompanied by symptoms such as chest pain, shortness of breath, weakness, vision changes or difficulty speaking can represent a medical emergency.
Previous chlorthalidone recall
The latest action follows an earlier 2026 recall involving chlorthalidone manufactured by Inventia Healthcare Limited.
That earlier recall involved 11,460 bottles of chlorthalidone tablets and was also associated with failed dissolution specifications. The earlier recall covered different batches and included both 100-tablet and 1,000-tablet bottles.
The existence of an earlier recall does not mean that all chlorthalidone products currently available in the United States are affected. Recalls generally apply to specified products, batches or packaging configurations.
What happens next?
The latest recall remains ongoing, and pharmacies, distributors and patients can use the FDA's enforcement information to identify affected products.
For people taking chlorthalidone, the key step is to verify whether their specific prescription is included rather than stopping treatment on their own.
Anyone who discovers that they have a recalled product should contact a pharmacist or healthcare professional for individualized instructions. Patients should also keep their medication information available, including the drug name, strength, lot number and prescribing details.
Blood pressure treatment can be highly individualized. A healthcare professional can determine whether a replacement medication or another supply of the same medicine is appropriate.
For the latest recall information, patients should rely on official FDA information and guidance from their healthcare professionals or pharmacists.
Sources
- U.S. Food and Drug Administration recall enforcement information concerning Inventia Healthcare Limited and chlorthalidone.
- MedlinePlus, National Library of Medicine, Chlorthalidone: Drug Information.
- American Heart Association, Managing High Blood Pressure Medications.
- American Heart Association, Home Blood Pressure Monitoring.
- American Heart Association, Understanding Blood Pressure Readings.
Medical Disclaimer
This article is provided for general informational purposes only and is not medical advice. A medication recall can involve specific lots, batches, strengths or package sizes, so readers should verify the exact product information with the FDA, their pharmacist or their healthcare professional. Do not stop, change or reduce a prescribed medication without professional medical guidance. If you believe you are experiencing a medical emergency, seek emergency medical care.